Lauren Haggerty1, Deanna Tran2. 1. 1 University of Maryland School of Pharmacy, Baltimore, MD, USA. 2. 2 Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Abstract
OBJECTIVE: To summarize the literature on cholesterol point-of-care tests (POCTs). This article would serve as a resource to assist community pharmacists in developing cholesterol point-of-care (POC) pharmacy services. DATA SOURCES: A literature search was performed in MEDLINE Ovid, PubMed, EMBASE, and Cochrane database using the following medical subject headings (MeSH) terms: point-of-care test, cholesterol, blood chemical analysis, rapid testing, collaborative practice, community pharmacy, and ambulatory care. Additional resources including device manufacturer web sites were summarized to supplement the current literature. STUDY SELECTION AND DATA EXTRACTION: All human research articles, review articles, meta-analyses, and abstracts published in English through September 1, 2014, were considered. DATA SYNTHESIS: A total of 36 articles were applicable for review. Information was divided into the following categories to be summarized: devices, pharmacists' impact, and operational cost for the pharmacy. CONCLUSIONS: The current literature suggests that POCTs in community pharmacies assist with patient outcomes by providing screenings and referring patients with dyslipidemia for further evaluation. The majority of studies on cholesterol POC devices focused on accuracy, revealing the need for further studies to develop best practices and practice models with successful reimbursement. Accuracy, device specifications, required supplies, and patient preference should be considered when selecting a POC device for purchase.
OBJECTIVE: To summarize the literature on cholesterol point-of-care tests (POCTs). This article would serve as a resource to assist community pharmacists in developing cholesterol point-of-care (POC) pharmacy services. DATA SOURCES: A literature search was performed in MEDLINE Ovid, PubMed, EMBASE, and Cochrane database using the following medical subject headings (MeSH) terms: point-of-care test, cholesterol, blood chemical analysis, rapid testing, collaborative practice, community pharmacy, and ambulatory care. Additional resources including device manufacturer web sites were summarized to supplement the current literature. STUDY SELECTION AND DATA EXTRACTION: All human research articles, review articles, meta-analyses, and abstracts published in English through September 1, 2014, were considered. DATA SYNTHESIS: A total of 36 articles were applicable for review. Information was divided into the following categories to be summarized: devices, pharmacists' impact, and operational cost for the pharmacy. CONCLUSIONS: The current literature suggests that POCTs in community pharmacies assist with patient outcomes by providing screenings and referring patients with dyslipidemia for further evaluation. The majority of studies on cholesterol POC devices focused on accuracy, revealing the need for further studies to develop best practices and practice models with successful reimbursement. Accuracy, device specifications, required supplies, and patient preference should be considered when selecting a POC device for purchase.
Entities:
Keywords:
POCT; cholesterol; community practice; hyperlipidemia; point-of-care tests
Authors: Sarah Pope; Hunter Hill; Lindsey Cardosi; Lindsey Henson; Mike Wasson; Sara Stallworth; Kim Ward; Shane P Desselle; Kenneth C Hohmeier Journal: Explor Res Clin Soc Pharm Date: 2021-06-10